Dear Scientist, Clinician or Visitor,

Welcome to MiSOT, our specialist expert consortium focused on the use of mesenchymal stem cell (MSC)-based technologies in solid organ transplantation and immune modulation.

MiSOT was formed in order to bring together academic and commercial research to enable accelerated development and assessment of therapeutic MSC-based technologies. We organize yearly international expert meetings, actively foster inter-laboratory exchange and scientific outreach and seek to identify new funding and collaboration possibilities.

If you wish to know more about our work, please contact us.


Prof. Marc-H Dahlke
MiSOT Founder

Department of Surgery
University Hospital Regensburg